Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6673
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study ; volume:3 ; number:1 ; day:18 ; month:12 ; year:2008 ; pages:1-7 ; date:12.2008
Journal of occupational medicine and toxicology ; 3, Heft 1 (18.12.2008), 1-7, 12.2008
- Urheber
-
Xanthopoulos, Athanasios
Bauer, Torsten T.
Blum, Torsten G.
Kollmeier, Jens
Schönfeld, Nicolas
Serke, Monika
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1745-6673-3-34
- URN
-
urn:nbn:de:101:1-2021083023080191457993
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xanthopoulos, Athanasios
- Bauer, Torsten T.
- Blum, Torsten G.
- Kollmeier, Jens
- Schönfeld, Nicolas
- Serke, Monika
- SpringerLink (Online service)
Ähnliche Objekte (12)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma